¼¼°è ¼Ò¾Æ¿ë ¹é½Å ½ÃÀå : 2033³â±îÁöÀÇ ±âȸ¿Í Àü·«
Pediatric Vaccine Global Market Opportunities And Strategies To 2033
»óǰÄÚµå : 1643990
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 286 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 7,060,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,590,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,120,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¼Ò¾Æ¿ë ¹é½Å ½ÃÀåÀº 2018³â¿¡ 297¾ï 5,009¸¸ ´Þ·¯°¡ µÇ¾î, 2023³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.00% ÀÌ»óÀ¸·Î ¼ºÀåÇß½À´Ï´Ù.

°³¹ß µµ»ó Áö¿ªÀÇ Ãâ»ý·ü Áõ°¡

°³¹ßµµ»óÁö¿ª¿¡¼­ÀÇ Ãâ»ý·ü Áõ°¡°¡ ÀÌ ½ÇÀû±â°£¿¡ À־ÀÇ ¼Ò¾Æ¿ë ¹é½Å ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇß½À´Ï´Ù. ½ÅÈï Áö¿ªÀÇ Ãâ»ý·üÀº »ê¾÷È­, ¼Òµæ ¼öÁØ ¹× °Ç°­ °ü¸®¿¡ ´ëÇÑ Á¢±ÙÀÌ ³·Àº ±¹°¡¿¡¼­ Àα¸ 1,000¸í ´ç Ãâ»ý ¼ö¸¦ ÀǹÌÇÕ´Ï´Ù. °³¹ßµµ»óÁö¿ª¿¡¼­ÀÇ Ãâ»ý·ü Áõ°¡´Â °¡Á·°èȹ¿¡ ´ëÇÑ Á¢±ÙÁ¦ÇÑ, ´ë°¡Á·À» ¼±È£ÇÏ´Â ¹®È­Àû ±Ô¹ü, ±³À° ¼öÁØÀÇ ³·À½, °æÁ¦Àû °úÁ¦, À¯¾Æ »ýÁ¸À²ÀÇ »ó½ÂÀ¸·Î À̾îÁö´Â ºÒÃæºÐÇÑ ÇコÄÉ¾î ¼­ºñ½º µîÀÇ ¿äÀο¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¸ñÂ÷

Á¦3Àå Ç¥ À϶÷

Á¦4Àå ±×¸² À϶÷

Á¦5Àå º¸°í¼­ ±¸¼º

Á¦6Àå ½ÃÀå Æ¯Â¡

Á¦7Àå ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦8Àå ¼Ò¾Æ¿ë ¹é½Å ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦9Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦10Àå ¼¼°èÀÇ ¼Ò¾Æ¿ë ¹é½Å ½ÃÀå : ¼¼ºÐÈ­

Á¦11Àå ¼Ò¾Æ¿ë ¹é½Å ½ÃÀå :Áö¿ª¡¤±¹°¡º° ºÐ¼®

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦13Àå ¼­À¯·´ ½ÃÀå

Á¦14Àå µ¿À¯·´ ½ÃÀå

Á¦15Àå ºÏ¹Ì ½ÃÀå

Á¦16Àå ³²¹Ì ½ÃÀå

Á¦17Àå Áßµ¿ ½ÃÀå

Á¦18Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦19Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦20Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦21Àå °æÀï º¥Ä¡¸¶Å·

Á¦22Àå °æÀï ´ë½Ãº¸µå

Á¦23Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦24Àå ±âȸ¿Í Àü·«

Á¦25Àå ¼Ò¾Æ¿ë ¹é½Å ½ÃÀå :°á·Ð°ú Á¦¾È

Á¦26Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Pediatric vaccines are immunizations specifically designed to protect children from various infectious diseases. These vaccines are administered during infancy and childhood from birth till 18 years. Moreover, these vaccines stimulate the immune system to recognize and combat pathogens, thereby preventing illnesses such as measles, mumps, rubella, polio and hepatitis.

The pediatric vaccine market consists of sales, by entities (organizations, sole traders and partnerships), of pediatric vaccine that are used by healthcare providers, including pediatricians, family physicians and public health clinics, who administer these vaccines according to established immunization schedules. Parents and guardians are also key stakeholders, ensuring their children receive timely vaccinations. Pediatric vaccines are typically administered during routine healthcare visits, starting from birth and continuing through adolescence, following schedules recommended by health authorities.

The global pediatric vaccine market was valued at $29,750.09 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

Increasing Birth Rates in Developing Regions

Increasing birth rates in developing regions drove the growth of the pediatric vaccine market during this historic period. Birth rates in developing regions refer to the number of live births per 1,000 people in countries with lower industrialization, income levels and access to healthcare. Increasing birth rates in developing regions can be attributed to factors such as limited access to family planning, cultural norms that favor larger families, lower levels of education, economic challenges and inadequate healthcare services that lead to higher infant survival rates.

Pediatric vaccines support increasing birth rates in developing regions by enhancing child survival, lowering infant mortality and improving overall health, which encourages families to have more children due to greater confidence in their children's well-being. For instance, in March 2024, according to Eurostat, a Belgium-based governing body, the number of live births in the EU increased slightly from 4.07 million in 2020 to 4.09 million in 2021. Therefore, increasing birth rates in developing regions contributed to the growth of the pediatric vaccine market.

Developing New Pediatric Vaccines For Better Public Health Outcomes

Major companies operating in the pediatric vaccine market are focusing on developing new vaccines for better public health outcomes. These vaccines, often included in national schedules, boost awareness and adoption among parents and healthcare providers. For example, in September 2024, Immunologicals Limited, an India-based pharmaceutical company specializing in vaccines and immunological products, launched Havisure Hepatitis A vaccine. Havisure Hepatitis A is a vaccine developed for pediatric use, offered in a 0.5 ml dosage to protect children against Hepatitis A, a highly contagious liver infection. This vaccine represents a significant step in India's commitment to providing affordable and effective immunization, particularly for vulnerable groups such as children. Its launch supports India's "Make in India" initiative, enhancing the country's vaccine self-sufficiency and contributing to better public health outcomes.

The global pediatric vaccine market is highly concentrated, with large players in the market. The top ten competitors in the market made up to 60.85% of the total market in 2023.

Pediatric Vaccine Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global pediatric vaccine market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Where is the largest and fastest-growing market for pediatric vaccine? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The pediatric vaccine market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider pediatric vaccine market; and compares it with other markets.

The report covers the following chapters

Markets Covered:

Table of Contents

1 Executive Summary

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

7 Major Market Trends

8 Pediatric Vaccine Market - Macro-Economic Scenario

9 Global Market Size and Growth

10 Global Pediatric Vaccine Market Segmentation

11 Pediatric Vaccine Market, Regional and Country Analysis

12 Asia-Pacific Market

13 Western Europe Market

14 Eastern Europe Market

15 North America Market

16 South America Market

17 Middle East Market

18 Africa Market

19 Competitive Landscape and Company Profiles

20 Other Major And Innovative Companies

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

24 Opportunities And Strategies

25 Pediatric Vaccine Market, Conclusions And Recommendations

26 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â